Sarah Allen

Dr. Sarah Allen

Department of Psychology, Northumbria University, Newcastle upon Tyne, UK
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
CFChristina M. Van Der Feltz-Cornelis
Christina M. Van Der Feltz-Cornelis
SASarah Allen
Sarah Allen
RHRichard I. G. Holt
Richard I. G. Holt
RRRichard Roberts
Richard Roberts
ANArie Nouwen
Arie Nouwen
Norman SaratoriusNorman Saratorius
Norman Saratorius
Objective: To provide an estimate of the effect of interventions on comorbid depressive disorder (MDD) or subthreshold depression in type 1 and type 2 diabetes.Methods: Systematic review and meta‐analysis. We searched PubMed, PsycINFO, Embase, and the Cochrane Library for randomized controlled trials evaluating the outcome of depression treatments in diabetes and comorbid MDD or subthreshold symptoms published before August 2019 compared to care as usual (CAU), placebo, waiting list (WL), or active comparator treatment as in a comparative effectiveness trial (CET). Primary outcomes were depressive symptom severity and glycemic control. Cohen's d is reported.Results: Forty‐three randomized controlled trials (RCTs) were selected, and 32 RCTs comprising 3,543 patients were included in the meta‐analysis. Our meta‐analysis showed that, compared to CAU, placebo or WL, all interventions showed a significant effect on combined outcome 0,485 (95% CI 0.360; 0.609). All interventions showed a significant effect on depression. Pharmacological treatment, group therapy, psychotherapy, and collaborative care had a significant effect on glycemic control. High baseline depression score was associated with a greater reduction in HbA1c and depressive outcome. High baseline HbA1c was associated with a greater reduction in HbA1c.Conclusion: All treatments are effective for comorbid depression in type 1 diabetes and type 2 diabetes. Over the last decade, new interventions with large effect sizes have been introduced, such as group‐based therapy, online treatment, and exercise. Although all interventions were effective for depression, not all treatments were effective for glycemic control. Effective interventions in comorbid depressive disorder may not be as effective in comorbid subthreshold depression. Baseline depression and HbA1c scores modify the treatment effect. Based on the findings, we provide guidance for treatment depending on patient profile and desired outcome, and discuss possible avenues for further research.

1 July 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Umair AkramUmair Akram
Umair Akram
AYAntonia Ypsilanti
Antonia Ypsilanti
MGMaria Gardani
Maria Gardani
KIKamila Irvine
Kamila Irvine
SASarah Allen
Sarah Allen
LLLambros Lazuras
Lambros Lazuras

1 November 2020 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
SASarah Allen
Sarah Allen
SGSimon Gilbody
Simon Gilbody
KAKarl Atkin
Karl Atkin
CFChristina van der Feltz-Cornelis
Christina van der Feltz-Cornelis


7 February 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
CFChristina M. Van Der Feltz-Cornelis
Christina M. Van Der Feltz-Cornelis
SASarah Allen
Sarah Allen
JSJonna F. Van Eck van der Sluijs
Jonna F. Van Eck van der Sluijs
Objective: Explore trauma, stress, and other predictive factors for treatment outcome in conversion disorder/functional neurological disorder (CD/FND).Methods: Prospective observational design. Clinical cohort study among consecutive outpatients with DSM‐IV CD/FND in a specialized mental health institution for somatic symptom disorders and related disorders (SSRD), presented between 1 February 2010 and 31 December 2017. Patient files were assessed for early childhood trauma, childhood sexual abuse, current stress, and other predictive factors. Patient‐related routine outcome monitoring (PROM) data were evaluated for treatment outcome at physical (Patient Health Questionnaire [PHQ15], Physical Symptoms Questionnaire [PSQ]) level as primary outcome, and depression (Patient Health Questionnaire [PHQ9]), anxiety (General Anxiety Disorder [GAD7]), general functioning (Short Form 36 Health Survey [SF36]), and pain (Brief Pain Inventory [BPI]) as secondary outcome.Results: A total of 64 outpatients were included in the study. 70.3% of the sample reported childhood trauma and 64.1% a recent life event. Mean scores of patients proceeding to treatment improved. Sexual abuse in childhood (F(1, 28) = 30.068,β = 0.608p < .001) was significantly associated with worse physical (PHQ15, PSQ) treatment outcome. 42.2% reported comorbid depression, and this was significantly associated with worse concomitant depressive (PHQ9) (F[1, 39] = 11.526,β = 0.478,p = .002) and anxiety (GAD7) (F[1,34] = 7.950,β = 0.435,p = .008) outcome.Conclusion: Childhood sexual abuse is significantly associated with poor treatment outcome in CD/FND. Randomized clinical trials evaluating treatment models addressing childhood sexual abuse in CD are needed.

3 June 2018 in British Journal of Health Psychology
Verified
Journal Article
Open access
PDF file
MSMichael Andrew Smith
Michael Andrew Smith
ATAlexandra Thompson
Alexandra Thompson
LHLynsey J. Hall
Lynsey J. Hall
SASarah Allen
Sarah Allen
MWMark Wetherell
Mark Wetherell
Objectives: Type D personality is associated with psychological and physical ill‐health. However, there has been limited investigation of the role of Type D personality in interventions designed to enhance well‐being. This study investigated associations between Type D personality and the efficacy of positive emotional writing for reducing stress, anxiety, and physical symptoms. Design: A between‐subjects longitudinal design was employed. Method: Participants ( N  =   71, M age = 28.2, SD age = 12.4) completed self‐report measures of Type D personality, physical symptoms, perceived stress, and trait anxiety, before completing either (1) positive emotional writing or (2) a non‐emotive control writing task, for 20 min per day over three consecutive days. State anxiety was measured immediately before and after each writing session, and self‐report questionnaires were again administered 4 weeks post‐writing. Results: Participants in the positive emotional writing condition showed significantly greater reductions in (1) state anxiety and (2) both trait anxiety and perceived stress over the 4‐week follow‐up period, compared to the control group. While these effects were not moderated by Type D personality, a decrease in trait anxiety was particularly evident in participants who reported both high levels of social inhibition and low negative affectivity. Linguistic analysis of the writing diaries showed that Type D personality was positively associated with swear word use, but not any other linguistic categories. Conclusion: These findings support the efficacy of positive emotional writing for alleviating stress and anxiety, but not perceived physical symptoms. Swearing may be a coping strategy employed by high Type D individuals. Statement of contribution: What is already known on this subject? Type D (distressed) personality is characterized by high levels of both negative affectivity and social inhibition, and has been associated with adverse physical and psychological health. Positive emotional writing is known to reduce subjectively reported physical symptoms and increase positive affect. What does this study add? Positive emotional writing was shown to attenuate (1) state anxiety immediately post‐writing, and (2) trait anxiety and perceived stress 4 weeks post‐writing. The findings demonstrate that positive writing might be a useful intervention for attenuating the adverse psychological effects of Type D personality in the general population. Type D personality was associated with more frequent use of swear words, which may be a coping mechanism used by high Type D individuals.